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Abstract
A 9-year-old male presented with a renal tumor that showed a cystic structure with calcification on computed
tomography. A pathological analysis of the resected tumor suggested clear cell sarcoma of the kidney (CCSK). Thus,
this patient suffered atypical CCSK with significant calcification and gross necrosis. A novel chromosomal
abnormality was also identified in the tumor.
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Background
Clear cell sarcoma of the kidney (CCSK) is a rare renal
tumor in children, second to Wilms tumor. CCSK repre-
sents 2–9 % of all pediatric renal tumors and generally
arises before the age of 5 years [1, 2]. The male-to-
female ratio is almost 2:1 [1, 2]. Its typical features are a
mucoid texture, necrotic foci, and prominent cyst forma-
tion. Multiple histological patterns (classic, myxoid,
sclerosing, cellular, epithelioid, palisading, spindle, stori-
form, and anaplastic) are blended together [1]. A CCSK
in a 9-year-old male is described with an atypical patho-
logical status, including gross necrosis and calcification.
Case presentation
A 9-year-old boy complained of abdominal bloating.
Blood parameters, including neuron specific enolase,
alpha fetoprotein, and beta human chorionic gonado-
tropin, were in the normal ranges, and his urinary vanil-
lylmandelic acid and homovanillic acid were not
elevated. Unenhanced abdominal computed tomography
(CT) revealed a tumor with calcification in the left kid-
ney, with infiltration of the renal sinus and 15 cm wide
(Fig. 1a). Contrast-enhanced CT revealed a heteroge-
neously enhancing mass completely enclosed by the
renal capsule (Fig. 1b). No metastasis was detected in
the lungs, liver, or bone by analysis of CT, magnetic res-
onance imaging and 99mTc scintigraphy. After complete
surgical resection, the tumor showed heterogeneous
pathological tissues divided by septa and included nec-
rotic tissue (Fig. 2). Calcification was found around the
necrotic tissue, but no macroscopic osteoplasty was ob-
served. Pathological analysis suggested a monomorphic
malignant neoplasm composed of plump or spindle-
shaped cells with elongated, vesicular nuclei or small nu-
clei and variable amounts of clear cytoplasm (Fig. 3).
These results prompted a diagnosis of stage 2 clear cell
sarcoma of the kidney (CCSK).
The 20 CCSK cells analyzed with fluorescence in
situ hybridization (FISH) had an abnormal karyotype,
46,XY,der(3)(3pter→ 3q23::7?::3?::7p13→ 7pter)der(7)(X
?::7p11.2→ 7q22::3?::Xq13→ Xqter)der(X)del(X)(p11.2
p22.1)t(X;7)(q11;?) (Fig. 4). This abnormal chromosome
has not been reported previously in CCSK.
Chemotherapy was administered according to the
Japanese Wilms Tumor Study (JWiTS)-2 Regimen I, includ-
ing vincristine, doxorubicin, and cyclophosphamide. The
patient has remained in complete remission for 3 years.
Discussion
In terms of its pathological features, CCSK is most com-
monly described as a tan-grey, soft, and mucoid mass on
cut section [1, 2]. Cystic foci are nearly universal and
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occasionally constitute the dominant feature, prompting
radiological and gross pathological diagnoses of multilo-
cular renal cyst [1, 2]. The microscopic appearance of
these lesions also mimics cystic nephroma. Within these
typically large and relatively homogeneous tumors,
discrete foci of necrosis and hemorrhage are common
on microscopic analysis [1, 2]. On the contrary, the
tumor in our patient appeared as a huge heterogeneous
cystic mass on enhanced CT. Gross and microscopic
pathological analysis showed that the cysts contained
necrotic tissues. These findings are not typical of CCSK.
Radiographically demonstrable calcification is ob-
served in 3–17 % of primary Wilms tumors [3, 4], but
calcification is rarely reported in CCSK. Glass et al. re-
ported calcification in CCSK, which was detected as
acoustic shadowing on sonography, indicating a calcific
deposit [5]. In the present case, calcification was de-
tected on CT. The pathological findings revealed that
the calcification was present around the sphacelus,
which is considered dystrophic calcification attributable
to necrosis [6]. These results suggest that huge areas of
necrosis and calcification are not reasons to reject a
diagnosis of CCSK.
The abnormal karyotype t(10;17)(q22;p13) has been re-
ported previously in CCSK [7], and CpG sites in the THBS1
gene were shown to be specifically hypermethylated in
CCSK [8]. A new chromosomal abnormality was detected
in our patient, 46,XY,der(3)(3pter→ 3q23::7?::3?::7p13→
7pter)der(7)(X?::7p11.2→ 7q22::3?::Xq13→Xqter)der(X)
del(X)(p11.2p22.1)t(X;7)(q11;?). A complex karyotype,
containing chromosomal 3, chromosomal 7, and X
chromosomal abnormalities, was detected with spectral
karyotyping FISH, in which a fragment of chromosome 7
was added to the partially deleted X chromosome. It is
unclear whether this abnormality was involved in the de-
velopment of CCSK, although renal cell sarcoma (RCC)
with an Xp11.2 translocation has been reported [9–11].
Calcification and CCSK occurrence, which were two fea-
tures of our patient, in an older child or young adult are
characteristics of RCC with the Xp11.2 translocation
[9–11]. Interestingly, both patients with Xp11.2 RCC
and our patient display X-chromosome abnormalities.
Fig. 1 Computed tomography (CT) findings. a Uncontrasted CT shows a tumor with calcification in the left kidney. b Contrast-enhanced CT
shows heterogeneous enhancement and completely enclosed by the renal capsule
Fig. 2 Gross pathological findings. The tumor weighed approximately
750 g and measured 15 × 12 × 9 cm. The left kidney is replaced by the
neoplasm. Calcification is apparent around the necrotic tissue
Fig. 3 Microscopic pathological analysis. Small oval cells arranged in
nests or cords are separated by fibrovascular septa. Plump or
spindle-shaped cells contain clear cytoplasm
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Therefore, it is likely that an X-chromosome aberra-
tion produces an atypical pathogenesis in CCSK, in-
cluding calcification and huge areas of necrosis.
CCSK is considered an unfavorable histological renal
tumor by the National Wilms Tumor Study Group
(NWTSG) and JWiTS [1, 2, 12–14]. The survival rate
for stage 2 CCSK is reported to be 75 % when doxorubi-
cin is added to the therapeutic regimen [1, 2, 13, 14].
However, necrosis is reported to increase the risk of
tumor-related mortality in CCSK [13]. Our patient re-
quires careful follow-up.
Conclusion
The calcification is not a reason to reject a diagnosis of
CCSK.
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